5[1]Martino R,Gomez L ,Pericas R et al.Bacteraemia caused by non-glucose-fermenting gram-negative bacilli and Aeromonas species in patients withhaemat ologicalmalignancies and solidtumours. Int J Infect Dis,2000; 4(2):85～90
6[2]Lopez-Hernandez S,Alarcon T, Delgado T et al. In vitro activity of beta-lactam agents and beta-lactamase inhibitors in clinical isolates of Acinetobacter baumannii. Rev Esp-Quimioter,1999;12(2): 140～143
7[5]Rodriguez-Hernandez MJ,Pachon J, Pichardo C,et al. Imipenem,doxycycline and amikacin in monotherapy and in combination in Acinetobacter baum annii experimental pneumonia. J Antimicrob Chemother,2000;45(4):493～501
8[6]Lai SW, Ng KC, Yu WL,et al. Acinetobacter baumannii bloodst reaminfection: clinical features and antimicrobial susceptibilities of isolates.Kao Hsiung I Hsueh Ko Hsueh Tsa Chih,1999;15(7):406～413
9[7]Husni RN, Goldstein LS, Arroliga AC,et al. Risk factors for an outbreak of multi-drug-resistant Acinetobacter nosoccmial pneumonia among intu bated patients [see comments] Chest, 1999; 115(5):1378～1382
10Zarrulli R, Cfispino M, Bagattini M, et al. Molecular epidemiology of sequential outbreaks of Acinetobacter baumannii in an intensive care unit shows the emergence of carbapenem resistance[ J]. J Clin Microbiol,2004,42(3 ) :946 - 953.
